Gene Expression and Mitotic Exit Induced by Microtubule-Stabilizing Drugs

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7891-7899

  Chen, Jie Guang ^a   Yang, Chia Ping Huang ^a   Cammer, Michael ^a   Horwitz, Susan Band ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); EPOTHILONE B; FAS ANTIGEN; ISOENZYME; ISOPROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PHOSPHOTRANSFERASE; PROTEIN P21; PROTEIN SUBUNIT; SURVIVIN;

ANEUPLOIDY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DEATH; CELL DIVISION; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS INHIBITION; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TETRAPLOIDY; UNINDEXED SEQUENCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EPOTHILONES; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MICROTUBULES; MITOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; POLYPLOIDY; RNA, MESSENGER;

EID: 0345275866     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Schiff, P. B., Fant, J., and Horwitz, S. B. Promotion of microtubule assembly in vitro by Taxol. Nature (Lond.), 277: 665-667, 1979.
2. Schiff, P. B., and Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
3. Yvon, A. M., Wadsworth, P., and Jordan, M. A. Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol. Biol. Cell, 10: 947-959, 1999.
4. Jordan, M. A., Toso, R. J., Thrower, D., and Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc. Natl. Acad. Sci. USA, 90: 9552-9556, 1993.
5. Yeung, T. K., Germond, C., Chen, X., and Wang, Z. The mode of action of Taxol: apoptosis at low concentration and necrosis at high concentration. Biochem. Biophys. Res. Commun., 263: 398-404, 1999.
6. Sena, G., Onado, C., Cappella, P., Montalenti, F., and Ubezio, P. Measuring the complexity of cell cycle arrest and killing of drugs: kinetics of phase-specific effects induced by Taxol. Cytometry, 37: 113-124, 1999.
7. Donaldson, K. L., Goolsby, G. L., Kiener, P. A., and Wahl, A. F. Activation of p34cdc2 coincident with Taxol-induced apoptosis. Cell Growth Differ., 5: 1041-1050, 1994.
8. Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D., and Lazarides, E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med., 1: 506-526, 1995.
9. Blagosklonny, M. V., and Fojo, T. Molecular effects of paclitaxel: myths and reality (a critical review). Int. J. Cancer, 83: 151-156, 1999.
10. Chen, J. G., and Horwitz, S. B. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res., 62: 1935-1938, 2002.
11. Torres, K., and Horwitz, S. B. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res., 58: 3620-3626, 1998.
12. 2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene, 20: 3806-3813, 2001.
13. Ryan, K. M., Phillips, A. C., and Vousden, K. H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol., 13: 332-337, 2001.
14. Ko, L. J., and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
15. Enoch, T., and Norbury, C. Cellular responses to DNA damage: cell-cycle check-points, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci., 20: 426-430, 1995.
16. Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., and Vogelstein, B. Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. USA, 96: 14517-14522, 1999.
17. Zhao, R., Gish, K., Murphy, M., Yin. Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., and Levine, A. J. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev., 14: 981-993, 2000.
18. Sorger, P. K., Dobles, M., Tournebize, R., and Hyman, A. A. Coupling cell division and cell death to microtubule dynamics, Curr. Opin. Cell Biol., 9: 807-814, 1997.
19. Casenghi, M., Mangiacasale, R., Tuynder, M., Caillet-Fauquet, P., Elhajouji, A., Lavia, P., Mousset, S., Kirsch-Volders, M., and Cundari, E. p53-independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells. Exp. Cell Res., 250: 339-350, 1999.
20. Kung, A. L., Sherwood, S. W., and Schimke, R. T. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl. Acad. Sci. USA, 87: 9553-9557, 1990.
21. Brichese, L., and Valette, A. PP1 phosphatase is involved in Bcl-2 dephosphorylation after prolonged mitotic arrest induced by paclitaxel. Biochem. Biophys. Res. Commun. 294: 504-508, 2002.
22. Andreassen, P. R., and Margolis, R. L. Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J. Cell Biol., 127: 789-802, 1994.
23. Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O., Chapel, L., Liesch, J., Goetz, M., Lazarides, E., and Woods, C. M. Epothilones, a new class of microtubule-stabilizing agents with a Taxol-like mechanism of action. Cancer Res., 55: 2325-2333, 1995.
24. Kowalski, R. J., Giannakakou, P., and Hamel, E. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol®). J. Biol. Chem., 272: 2534-2541, 1997.
25. McDaid, H. M., Mani, S., Shen, H. J., Muggia, F., Sonnichsen, D., and Horwitz, S. B. Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a Phase I clinical study. Clin. Cancer Res., 8: 2035-2043, 2002.
26. Rajeevan, M. S., Ranamukhaarachchi, D. G., Vernon, S. D., and Unger, E. R. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies, Methods. 25: 443-451, 2001.
27. 1 phase microtubule integrity and is crucial for restriction point transition. Cell Cycle, 1: 327-336, 2002.
28. 1-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol. Cell. Biol., 20: 1797-1815, 2000.
29. Muller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., and Krammer, P. H. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med., 188: 2033-2045, 1998.
30. Timmer, T., de Vries, E. G., and de Jong, S. Fas receptor-mediated apoptosis: a clinical application? J. Pathol., 196: 125-134, 2002.
31. Odoux, C., Albers, A., Amoscato, A. A., Lotze, M. T., and Wong, M. K. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer. Int. J. Cancer, 97: 458-465, 2002.
32. Ferreira, C. G., Tolis, C., Span, S. W., Peters, G. J., van Lopik, T., Kummer, A. J., Pinedo, H. M., and Giaccone, G. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway. Clin. Cancer Res., 6: 203-212, 2000.
33. Micheau, O., Solary, E., Hammann, A., and Dimanche-Boitrel, M. T. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem., 274: 7987-7992, 1999.
34. Blagosklonny, M. V., Robey, R., Sheikh, M. S., and Fojo, T. Paclitaxel-induced FasL-independent apoptosis and slow (non-apoptotic) cell death. Cancer Biol. Ther., 1: 113-117, 2002.
35. Duriez, P. J., and Shah, G. M. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell Biol., 75: 337-349, 1997.
36. cdc2 survival checkpoint in cancer. Cancer Cell, 2: 43-54, 2002.
37. Stewart, Z. A., Tang, L. J., and Pietenpol, J. A. Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner. Oncogene, 20: 113-124, 2001.
38. Giannakakou, P., Nakano, M., Nicolaou, K. C., O'Brate, A., Yu, J., Blagosklonny, M. V., Greber, U. F., and Fojo, T. Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc. Natl. Acad. Sci. USA, 99: 10855-10856, 2002.
39. Jimenez, G. S., Khan, S. H., Stommel, J. M., and Wahl, G. M. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene, 18: 7656-7665, 1999.
40. Bargonetti, J., and Manfredi, J. J. Multiple roles of the tumor suppressor p53. Curr. Opin. Oncol., 14: 86-91, 2002.
41. Kannan, K., Amariglio, N., Rechavi, G., Jakob-Hirsch, J., Kela, I., Kaminski, N., Getz, G., Domany, E., and Givol. D. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene, 20: 2225-2234, 2001.
42. Tan, M., Wang, Y., Guan, K., and Sun, Y., PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway. Proc. Natl. Acad. Sci. USA, 97: 109-114, 2000.
43. Ewan, K. B., Henshall-Powell, R. L., Ravani, S. A., Pajares, M. J., Arteaga, C., Warters, R., Akhurst, R. J., and Barcellos-Hoff, M. H Transforming. growth factor-β mediates cellular response to DNA damage in situ. Cancer Res., 62: 5627-5631, 2002.
44. 2/M west, DNA repair, and cell death in keratinocytes following ultraviolet exposure. J. Investig. Dermatol., 119: 22-26, 2002.
45. Lichtner, R. B., Rotgeri, A., Bunte, T., Buchmann, B., Hoffmann, J., Schwede, W., Skuballa, W., and Klar, U. Subcellular distribution of epothilones in human tumor cells. Proc. Natl. Acad. Sci. USA, 98: 11743-11748, 2001.
46. 2/M transition by p53. Oncogene, 20: 1803-1815, 2001.
47. Martinez-Exposito, M. J., Kaplan, K. B., Copeland, J., and Sorger, P. K. Retention of the BUB3 checkpoint protein on lagging chromosomes. Proc. Natl. Acad. Sci. USA, 96: 8493-8498, 1999.
48. Wang, Y., and Burke, D. J. Checkpoint genes required to delay cell division in response to nocodazole respond to impaired kinetochore function in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol., 15: 6838-6844, 1995.
49. Paoletti, A., Giocanti, N., Favaudon, V., and Bomens, M. Pulse treatment of interphasic HeLa cells with nanomolar doses of docetaxel affects centrosome organization and leads to catastrophic exit of mitosis. J. Cell Sci., 110: 2403-2415, 1997.
50. Yu, D., Jing, T., Liu, B., Yao, J., Tan, M., McDonnell, T. J., and Hung, M. C. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Mol. Cell, 2: 581-591. 1998.
51. 2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs. Oncogene, 21: 6249-6254, 2002.
52. 2/M arrest and apoptosis. Nat. Med., 2: 72-79, 1996.
53. Shen, S. C., Huang, T. S., Jee, S. H., and Kuo, M. L. Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells. Cell Growth Differ., 9: 23-29, 1998.
54. Tsuiki, H., Nitta, M., Tada, M., Inagaki, M., Ushio, Y., and Saya, H. Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines. Oncogene, 20: 420-429. 2001.
55. Waf1/Cip1 inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol. Cell. Biol., 19: 205-215, 1999.
56. Lanzi, C., Cassinelli, G., Cuccuru, G., Supino, R., Zuco, V., Ferlini, C., Scambia, G., and Zunino, F. Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells. Prostate, 48: 254-264, 2001.
57. Schimke, R. T., Kung, A., Sherwood, S. S., Sheridan, J., and Sharma, R. Life, death and genomic change in perturbed cell cycles. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 345: 311-317, 1994.
58. Ashcroft, M., Taya, Y., and Vousden, K. H. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol., 20: 3224-3233, 2000.
59. Blajeski, A. L., Kottke, T. J., and Kaufmann, S. H. A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines. Exp. Cell Res., 270: 277-288, 2001.
60. Fujikawa-Yamamoto, K., Ohdoi, C., Yamagishi, H., Zong, Z. P., Murakami, M., and Yamaguchi, N. Lack of synchrony among multiple nuclei induces partial DNA fragmentation in V79 cells polyploidized by demecolcine. Cell Prolif., 32: 337-349, 1999.
61. Elhajouji, A., Cunha, M., and Kirsch-Volders, M. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis, 13: 193-198, 1998.
62. 2 arrest in response to overexpression of p53. Mol. Biol. Cell, 10: 3607-3622, 1999.
63. Meek, D. W. The role of p53 in the response to mitotic spindle damage. Pathol. Biol., 48: 246-254, 2000.
64. Hu, F., and Elledge, S. J. Bub2 is a cell cycle regulated phospho-protein controlled by multiple checkpoints. Cell Cycle, 1: 351-355, 2002.
65. Iancu, C., Mistry, S. J., Arkin, S., and Atweh, G. F. Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle. Cancer Res., 60: 3537-3541, 2000.
66. Wittmann, S., Bali, P., Donapaty, S., Nimmanapalli, R., Guo, F., Yamaguchi, H., Huang, M., Jove, R., Wang, H. G., and Bhalla, K. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. Cancer Res., 63: 93-99, 2003.
67. 2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein. Mol. Pharmacol., 55: 1088-1093, 1999.
68. Barboule, N., Chadebech, P., Baldin, V., Vidal, S., and Valette, A. Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line. Oncogene, 15: 2867-2875, 1997.